Quality by Design: Industrial Case Studies on Defining and Implementing Design Space for Pharmaceutical Processes (Part 2) - Understanding the relationship between the process and CQAs. - BioPharm

ADVERTISEMENT

Quality by Design: Industrial Case Studies on Defining and Implementing Design Space for Pharmaceutical Processes (Part 2)
Understanding the relationship between the process and CQAs.


BioPharm International
Volume 22, Issue 1

REFERENCES

1. US Food and Drug Administration. Guidance for industry. Q8 pharmaceutical development. Rockville, MD: 2006 May.

2. US FDA. PAT Guidance for industry. A framework for innovative pharmaceutical development, manufacturing and quality assurance. Rockville, MD: 2004 Sept.

3. Gnoth S, Jenzsch M, Simutis R, Lübbert A. Process analytical technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control. J Biotechnol. 2007;132:180–6.

4. Kirdar AO, Conner JS, Baclaski J, Rathore AS. Application of multivariate analysis towards biotech processes: Case study of a cell-culture unit operation. Biotech Prog. 2007;23:61–7.

5. Johnson R, Yu O, Kirdar AO, Annamalai A, Ahuja S, Ram K, Rathore, AS. Applications of multivariate data analysis (MVDA) for biotech processing. BioPharm Int. 2007 Oct;20(10):130–44.

6. Kirdar AO, Green KD, Rathore AS. Application of multivariate analysis for identification and resolution of a root cause for a bioprocessing application. Biotech Prog. 2008;24:720–6.

7. Rathore AS, Sharma A, Chillin D. Applying process analytical technology to biotech unit operations. BioPharm Int. 2006 Aug; 19(8):48–57.

8. Rathore AS, Yu M, Yeboah S, Sharma A. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high performance liquid chromatography (HPLC) for making real time pooling decisions for process chromatography. Biotechnol Bioeng. 2008;100:306–16.

9. Rathore AS, Branning R, Cecchini D. Design space for biotech products. BioPharm Intl. 2007 April;20(4):36–40.

10. US FDA. Guidance for Industry: Q10 quality systems approach to pharmaceutical CGMP regulations. Rockville, MD: 2006 Sept.

11. Kozlowski S, Swann P. Current and future issues in the manufacturing and development of monoclonal antibodies. Adv Drug Deliv Rev. 2006;58:707–22.

12. Harms J, Wang X, Kim T, Yang J, Rathore AS. Defining design space for biotech products: case study of Pichia pastoris fermentation. Biotechnol Prog. 2008;24:655–62.

13. Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu H, Hussain AS. Applications of process analytical technology to crystallization process. Adv Drug Deliv Rev. 2004;56:349–69.


blog comments powered by Disqus

ADVERTISEMENT

Pfizer Wins Multibillion-Dollar Settlement from Teva and Sun for Infringement of Protonix Patent
June 19, 2013
Elan Proceeds with Formal Sale Process of Company; Royalty Pharma Drops Bid
June 19, 2013
J&J to Acquire Aragon Pharmaceuticals
June 19, 2013
AstraZeneca Selects Cambridge, UK for New Global R&D Center and Corporate HQ
June 19, 2013
GSK Receives Offer for its Thrombosis Brands and Related Manufacturing Site
June 19, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here